A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines-Reference-Cited by-同舟云学术

A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines

Published:2015-07-30 Issue:1 Volume:15 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Guerrero Anna Melissa,Genuino Anne Julienne,Santillan Melanie,Praditsitthikorn Naiyana,Chantarastapornchit Varit,Teerawattananon Yot,Alejandria Marissa,Toral Jean Anne

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/article/10.1186/s12889-015-2046-1/fulltext.html

Reference52 articles.

1. WHO Globocan Fact Sheet 2008 for the Philippines [ http://globocan.iarc.fr/Pages/fact_sheets_population.aspx ]

2. Domingo EJ, Dy Echo AVV. Epidemiology, prevention and treatment of cervical cancer in the Philippines. J Gynecol Oncol. 2009;20(1):11–6.

3. Domingo EJ, Noviani R, Noor MRM, Ngelangel CA, Limpaphayom KK, Van Thuan T, et al. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine. 2008;26:M71–9.

4. Society PC. Philippine Cancer Facts and Estimates 2010. Manila: Philippine Cancer Society Manila Cancer Registry and the Department of Health Rizal Cancer Registry; 2010.

5. WHO/ICO. Human Papillomavirus and Related Cancers Summary Report 2010 for the Philippines. Barcelona, Spain: WHO/ICO Information Centre on HPV and Cervical Cancer; 2010.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Influencing Cervical Cancer Screening Uptake among Reproductive-Aged Filipino Women: Findings from the 2022 Philippines National Demographic and Health Survey;Women's Health Reports;2024-04-01

2. Cost-effectiveness and public health impact of typhoid conjugate vaccine introduction strategies in Bangladesh;Vaccine;2024-04

3. International Partnerships to Develop Evidence-informed Priority Setting Institutions: Ten Years of Experience from the International Decision Support Initiative (iDSI);Health Systems & Reform;2023-12-31

4. Determinants of Acquisition, Persistence, and Clearance of Oncogenic Cervical Human Papillomavirus Infection in the Philippines Using a Multi-Omics Approach: DEFEAT HPV Study Protocol;Healthcare;2023-02-23

5. Breast and cervical cancer screening in the Philippines: Challenges and steps forward;Preventive Medicine Reports;2022-10